Physician profile
Dale E Scanlan
NPI 1437532728
$604.56
in general payments reported to CMS, 2019-2025
9 companies · $83.65 in 2025
The $83.65 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $18.58 · 2023: $211 · 2024: $14.04 · 2025: $83.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $168.33 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Medical Device Business Services, INC. | $125.09 | 2021 | |
| Boston Scientific Corporation | $113.94 | 2023 | |
| Route 92 Medical, INC. | $50.23 | 2025 | |
| Cardinal Health 200 LLC | $40.60 | 2021 | |
| Terumo Medical Corporation | $34.17 | 2021-2024 | Angio-Seal, Glidesheath Slender |
| Microvention, INC. | $33.42 | 2025 | Web Aneurysm Embolization System |
| Smith+Nephew, INC. | $20.60 | 2023 | Stravix |
| Medtronic, INC. | $18.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Scanlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.